WORLD-FIRST ACHIEVED: Today has been an emotional day for the Newrotex Team as our first product SilkAxons was successfully implanted into a patient to repair their large nerve gap (10cm)!

For patients with large-gap peripheral nerve injuries, today’s options often fall short — leaving many facing lifelong disability, loss of function, and a limited quality of life. Our goal with SilkAxons is to change that.

This trial represents an important step toward offering a new treatment designed to restore function and independence for people who currently have few effective options. While it’s early days, this first enrollment is a milestone that brings us closer to making a real difference for patients and their families.

Alex, our CEO says “As a previous Zoologist turned Trauma & Orthopaedic surgeon, I was first struck by the challenges of treating patients with nerve injuries during my early surgical training. Years later through research and collaborations we ultimately founded Newrotex with a vision to create something better for those patients. And it’s been a rollercoaster of the highs and lows of innovation – but always with the belief that we could make a difference. Today that belief became real”. 

We want to congratulate Dr Ricard Bermudez and his fantastic team at the Panama Clinic for achieving this Word First implantation bridging a gap larger than anything on the market can currently achieve. 

We are deeply grateful to the clinicians, trial teams, and most of all the patients who make this progress possible.

As we continue this journey, we’re also mindful that addressing this profound unmet need represents not only an opportunity to change lives but also to build the foundation for a new standard of care in nerve repair — one with significant clinical and market impact.